Skip to main content

Advertisement

SpringerLink
Log in

Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Hemangioblastoma is composed of neoplastic stromal cells and a prominent capillary network. To date, the identity of stromal cells remains unclear. Mesenchymal stem cells can give rise to committed vascular progenitor cells, and ephrin-B2/EphB4 and Notch signaling have crucial roles in these steps. The aim of our study was to elucidate that stromal cells of central nervous system hemangioblastomas have mesenchymal stem cell-derived vascular progenitor cell properties. Ten hemangioblastomas were investigated immunohistochemically. CD44, a mesenchymal stem cell marker, was detected in stromal cells of all cases, suggesting that stromal cells have mesenchymal stem cell-like properties. Neither CD31 nor α-SMA was expressed in stromal cells, suggesting that stromal cells have not acquired differentiated vascular cell properties. Both ephrin-B2 and EphB4, immature vascular cell markers, were detected in stromal cells of all cases. Jagged1, Notch1, and Hesr2/Hey2, which are known to be detected in both immature endothelial cells and mural cells, were expressed in stromal cells of all cases. Notch3, which is known to be detected in differentiating mural cells, was also expressed in all cases. These results suggest that stromal cells also have vascular progenitor cell properties. In conclusion, stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rachinger J, Buslei R, Prell J et al (2009) Solid haemangioblastomas of the CNS: a review of 17 consecutive cases. Neurosurg Rev 32:37–47 (discussion 47–48)

    Article  PubMed  Google Scholar 

  2. Merrill MJ, Edwards NA, Lonser RR (2011) Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas. J Neurosurg 115:512–517

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hussein MR (2007) Central nervous system capillary haemangioblastoma: the pathologist’s viewpoint. Int J Exp Pathol 88:311–324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bamps S, Calenbergh FV, Vleeschouwer SD et al (2013) What the neurosurgeon should know about hemangioblastoma, both sporadic and in Von Hippel-Lindau disease: a literature review. Surg Neurol Int 4:145

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hojo M, Arakawa Y, Funaki T et al (2014) Usefulness of tumor blood flow imaging by intraoperative indocyanine green videoangiography in hemangioblastoma surgery. World Neurosurg 82:e495–e501

    Article  PubMed  Google Scholar 

  6. Spence AM, Rubinstein LJ (1975) Cerebellar capillary hemangioblastoma: its histogenesis studied by organ culture and electron microscopy. Cancer 35:326–341

    Article  CAS  PubMed  Google Scholar 

  7. Ding XH, Zhou LF, Tan YZ et al (2007) Histologic and histogenetic investigations of intracranial hemangioblastomas. Surg Neurol 67:239–245 (discussion 245)

    Article  PubMed  Google Scholar 

  8. Lach B, Gregor A, Rippstein P et al (1999) Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohistochemical study. Ultrastruct Pathol 23:299–310

    Article  CAS  PubMed  Google Scholar 

  9. Ishizawa K, Komori T, Hirose T (2005) Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma. Pathol Int 55:377–385

    Article  PubMed  Google Scholar 

  10. Ma D, Zhang M, Chen L et al (2011) Hemangioblastomas might derive from neoplastic transformation of neural stem cells/progenitors in the specific niche. Carcinogenesis 32:102–109

    Article  CAS  PubMed  Google Scholar 

  11. Ma D, Zhu W, Zhang M et al (2011) Identification of tumorigenic cells and implication of their aberrant differentiation in human hemangioblastomas. Cancer Biol Ther 12:727–736

    Article  CAS  PubMed  Google Scholar 

  12. Park DM, Zhuang Z, Chen L et al (2007) von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med 4:e60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Epari S, Bhatkar R, Moyaidi A et al (2014) Histomorphological spectrum and immunohistochemical characterization of hemangioblastomas: an entity of unclear histogenesis. Indian J Pathol Microbiol 57:542–548

    Article  PubMed  Google Scholar 

  14. Shively SB, Beltaifa S, Gehrs B et al (2008) Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease. J Pathol 216:514–520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Stein AA, Schilp AO, Whitfield RD (1960) The histogenesis of hemangioblastoma of the brain. A review of twenty-one cases. J Neurosurg 17:751–761

    Article  CAS  PubMed  Google Scholar 

  16. Welten CM, Keats EC, Ang LC et al (2012) Hemangioblastoma stromal cells show committed stem cell phenotype. Can J Neurol Sci 39:821–827

    Article  PubMed  Google Scholar 

  17. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  CAS  PubMed  Google Scholar 

  18. Reyes M, Dudek A, Jahagirdar B et al (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Investig 109:337–346

    Article  CAS  PubMed  Google Scholar 

  19. Zhang G, Zhou J, Fan Q et al (2008) Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation. FEBS Lett 582:2957–2964

    Article  CAS  PubMed  Google Scholar 

  20. Liu Y, Deng B, Zhao Y et al (2013) Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells. Dev Growth Differ 55:591–605

    Article  CAS  PubMed  Google Scholar 

  21. Lin CH, Lilly B (2014) Endothelial cells direct mesenchymal stem cells toward a smooth muscle cell fate. Stem Cells Dev 23:2581–2590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Duffy GP, D’Arcy S, Ahsan T et al (2010) Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential. Tissue Eng Part A 16:2755–2768

    Article  CAS  PubMed  Google Scholar 

  23. Kurpinski K, Lam H, Chu J et al (2010) Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28:734–742

    Article  CAS  PubMed  Google Scholar 

  24. Foo SS, Turner CJ, Adams S et al (2006) Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124:161–173

    Article  CAS  PubMed  Google Scholar 

  25. Wang HU, Chen ZF, Anderson DJ (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741–753

    Article  CAS  PubMed  Google Scholar 

  26. Adams RH, Wilkinson GA, Weiss C et al (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295–306

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Hashimoto T, Tsuneki M, Foster TR et al (2016) Membrane-mediated regulation of vascular identity. Birth Defects Res C Embryo Today 108:65–84

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fischer A, Schumacher N, Maier M et al (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901–911

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Fischer A, Gessler M (2003) Hey genes in cardiovascular development. Trends Cardiovasc Med 13:221–226

    Article  CAS  PubMed  Google Scholar 

  30. Kageyama R, Ohtsuka T, Shimojo H et al (2008) Dynamic Notch signaling in neural progenitor cells and a revised view of lateral inhibition. Nat Neurosci 11:1247–1251

    Article  CAS  PubMed  Google Scholar 

  31. Lawson ND, Scheer N, Pham VN et al (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675–3683

    CAS  PubMed  Google Scholar 

  32. Hofmann JJ, Iruela-Arispe ML (2007) Notch signaling in blood vessels: who is talking to whom about what? Circ Res 100:1556–1568

    Article  CAS  PubMed  Google Scholar 

  33. Villa N, Walker L, Lindsell CE et al (2001) Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 108:161–164

    Article  CAS  PubMed  Google Scholar 

  34. Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21:2511–2524

    Article  CAS  PubMed  Google Scholar 

  35. Swift MR, Weinstein BM (2009) Arterial-venous specification during development. Circ Res 104:576–588

    Article  CAS  PubMed  Google Scholar 

  36. Lonser RR, Glenn GM, Walther M et al (2003) von Hippel-Lindau disease. The Lancet 361:2059–2067

    Article  CAS  Google Scholar 

  37. Takada S, Hojo M, Tanigaki K et al (2017) Contribution of endothelial-to-mesenchymal transition to the pathogenesis of human cerebral and orbital cavernous malformations. Neurosurgery 81:176–183

    Article  PubMed  Google Scholar 

  38. Takada S, Hojo M, Takebe N et al (2018) Role of endothelial-to-mesenchymal transition in the pathogenesis of central nervous system hemangioblastomas. World Neurosurg. https://doi.org/10.1016/j.wneu.2018.05.235 (in press)

    Article  PubMed  Google Scholar 

  39. Aruffo A, Stamenkovic I, Melnick M et al (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–1313

    Article  CAS  PubMed  Google Scholar 

  40. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33–45

    Article  CAS  PubMed  Google Scholar 

  41. Oswald J, Boxberger S, Jrgensen B et al (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377–384

    Article  PubMed  Google Scholar 

  42. Boxall SA, Jones E (2012) Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012:975871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Böhling T, Mäenpää A, Timonen T et al (1996) Different expression of adhesion molecules on stromal cells and endothelial cells of capillary hemangioblastoma. Acta Neuropathol 92:461–466

    Article  PubMed  Google Scholar 

  44. Bai J, Wang YJ, Liu L et al (2014) Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation. J Int Med Res 42:405–415

    Article  CAS  PubMed  Google Scholar 

  45. Erber R, Eichelsbacher U, Powajbo V et al (2006) EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25:628–641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hill-Felberg S, Wu HH, Toms SA et al (2015) Notch receptor expression in human brain arteriovenous malformations. J Cell Mol Med 19:1986–1993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Boucher J, Gridley T, Liaw L (2012) Molecular pathways of notch signaling in vascular smooth muscle cells. Front Physiol 3:81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Li S, Wang R, Wang Y et al (2014) Receptors of the Notch signaling pathway are associated with hemorrhage of brain arteriovenous malformations. Mol Med Rep 9:2233–2238

    Article  CAS  PubMed  Google Scholar 

  49. Yamashita J, Itoh H, Hirashima M et al (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92–96

    Article  CAS  PubMed  Google Scholar 

  50. Boscolo E, Stewart CL, Greenberger S et al (2011) JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:2181–2192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Alles JU, Bosslet K, Schachenmayr W (1986) Hemangioblastoma of the cerebellum—an immunocytochemical study. Clin Neuropathol 5:238–241

    CAS  PubMed  Google Scholar 

  52. Jurco SR, Nadji M, Harvey DG et al (1982) Hemangioblastomas: histogenesis of the stromal cell studied by immunocytochemistry. Hum Pathol 13:13–18

    Article  PubMed  Google Scholar 

  53. Mizuno J, Iwata K, Takei Y (1993) Immunohistochemical study of hemangioblastoma with special reference to its cytogenesis. Neurol Med Chir (Tokyo) 33:420–424

    Article  CAS  Google Scholar 

  54. Bleistein M, Geiger K, Franz K et al (2000) Transthyretin and transferrin in hemangioblastoma stromal cells. Pathol Res Pract 196:675–681

    Article  CAS  PubMed  Google Scholar 

  55. Becker I, Paulus W, Roggendorf W (1989) Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study. Am J Pathol 134:271–275

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Nemes Z (1992) Fibrohistiocytic differentiation in capillary hemangioblastoma. Hum Pathol 23:805–810

    Article  CAS  PubMed  Google Scholar 

  57. Adams SA, Hilton DA (2002) Recurrent haemangioblastoma with glial differentiation. Neuropathol Appl Neurobiol 28:142–146

    Article  CAS  PubMed  Google Scholar 

  58. Tanimura A, Nakamura Y, Hachisuka H et al (1984) Hemangioblastoma of the central nervous system: nature of the stromal cells as studied by the immunoperoxidase technique. Hum Pathol 15:866–869

    Article  CAS  PubMed  Google Scholar 

  59. Gläsker S, Li J, Xia JB et al (2006) Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res 66:4167–4172

    Article  PubMed  Google Scholar 

  60. Shively SB, Falke EA, Li J et al (2011) Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease. Mod Pathol 24:1023–1030

    Article  PubMed  PubMed Central  Google Scholar 

  61. Vortmeyer AO, Frank S, Jeong SY et al (2003) Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res 63:7051–7055

    CAS  PubMed  Google Scholar 

  62. Venkatesh V, Nataraj R, Thangaraj GS et al (2018) Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig 5:5

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Japan Society for the Promotion of Science (16689024 to Masato Hojo). We thank Ryota Ito, Mafumi Kurozumi and Toshiaki Manabe for technical assistance.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Kyoto University Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Shigeki Takada, Masato Hojo, Noriyoshi Takebe & Susumu Miyamoto

  2. Research Institute, Shiga Medical Center, 5-4-30, Moriyama, Moriyama, Shiga, 524-8524, Japan

    Shigeki Takada, Noriyoshi Takebe & Kenji Tanigaki

  3. Department of Neurosurgery, Shiga Medical Center for Adults, 5-4-30, Moriyama, Moriyama, Shiga, 524-8524, Japan

    Masato Hojo

Authors
  1. Shigeki Takada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masato Hojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noriyoshi Takebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenji Tanigaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susumu Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masato Hojo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takada, S., Hojo, M., Takebe, N. et al. Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties. Brain Tumor Pathol 35, 193–201 (2018). https://doi.org/10.1007/s10014-018-0323-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-018-0323-2

Keywords

Search

Navigation